Option chain shows key data for Lisata Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Lisata Therapeutics.

Lisata Therapeutics (NASDAQ:LSTA) Stock, Option Chain

LISATA THERAPEUTICS INC

Lisata Therapeutics

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

abbott shutter

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ABSI

AGYS

BLBX

HEPA

LSTA

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

Procter & Gamble p&g shutter

Nasdaq Surges 1.5%; Procter &amp; Gamble Posts Upbeat Earnings

Programmer,Working,In,A,Software,Developing,Company,Office

ASST

NFLX

STFS

US Stocks Higher; Netflix Profit Beats Estimates

Lisata Therapeutics Inc

Press Releases

Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference

Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025

Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

General

Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development

Lisata Therapeutics to Present at the Investival Showcase USA

Lisata Therapeutics Announces Research License with Catalent

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Health Care

Lisata Therapeutics to Present at the 2025 BIO International Convention

Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development

HC Wainwright & Co.

Comments

Lisata Therapeutics

Lisata Therapeutics (LSTA) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell